Overview

A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The primary objective will be to compare the impact of the study formulations on pulmonary function in persistent asthma carriers.
Phase:
Phase 3
Details
Lead Sponsor:
Eurofarma Laboratorios S.A.
Treatments:
Fluticasone
Formoterol Fumarate
Xhance